Five months after announcing it, GlaxoSmithKline confirmed it has completed the spin-off of its consumer division, which is now officially operating as Haleon. The name change applies to Glaxo’s manufacturing plant in Guayama. The new ...
Business is on track to spin-off the unit and list it as a new company in mid-2022.